NAM
RMD icon

Nutshell Asset Management’s ResMed RMD Stock Holding History

Nutshell Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.18M Buy
+36,430
New +$9.08M 4.44% 10
2025
Q2 		– Sell
-14,050
Closed -$3.15M – 33
2025
Q1 		$3.15M Buy
14,050
+4,304
+44% +$1M 1.64% 21
2024
Q4 		$2.23M Buy
+9,746
New +$2.35M 1.41% 23

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nutshell Asset Management's RMD Position: Q1 2026 in Review

Nutshell Asset Management opened a new position in ResMed (RMD) in Q1 2026: 36,430 shares worth $8.18M. The stake represents 4.44% of the portfolio and ranks #10 among its holdings. This is a return to the name: Nutshell Asset Management previously reported a position in RMD as recently as Q1 2025.

Nutshell Asset Management first reported a position in RMD in Q4 2024 and has held it in 3 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Nutshell Asset Management held 36,430 shares of ResMed worth $8.18M as of Q1 2026.
  • ResMed was a new Nutshell Asset Management position in Q1 2026.
  • ResMed made up 4.44% of Nutshell Asset Management's portfolio in Q1 2026, its #10 holding.
  • Nutshell Asset Management first reported a position in ResMed in Q4 2024 and has held it in 3 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Nutshell Asset Management's 13F filing for Q1 2026, filed 14 May 2026.